title: Proteomics analysis of the cardiac myofilament subproteome reveals dynamic alterations in phosphatase subunit distribution.
abstract: Myofilament proteins are responsible for cardiac contraction. The myofilament subproteome, however, has not been comprehensively analyzed thus far. In the present study, cardiomyocytes were isolated from rodent hearts and stimulated with endothelin-1 and isoproterenol, potent inducers of myofilament protein phosphorylation. Subsequently, cardiomyocytes were "skinned," and the myofilament subproteome was analyzed using a high mass accuracy ion trap tandem mass spectrometer (LTQ Orbitrap XL) equipped with electron transfer dissociation. As expected, a small number of myofilament proteins constituted the majority of the total protein mass with several known phosphorylation sites confirmed by electron transfer dissociation. More than 600 additional proteins were identified in the cardiac myofilament subproteome, including kinases and phosphatase subunits. The proteomic comparison of myofilaments from control and treated cardiomyocytes suggested that isoproterenol treatment altered the subcellular localization of protein phosphatase 2A regulatory subunit B56alpha. Immunoblot analysis of myocyte fractions confirmed that beta-adrenergic stimulation by isoproterenol decreased the B56alpha content of the myofilament fraction in the absence of significant changes for the myosin phosphatase target subunit isoforms 1 and 2 (MYPT1 and MYPT2). Furthermore, immunolabeling and confocal microscopy revealed the spatial redistribution of these proteins with a loss of B56alpha from Z-disc and M-band regions but increased association of MYPT1/2 with A-band regions of the sarcomere following beta-adrenergic stimulation. In summary, we present the first comprehensive proteomics data set of skinned cardiomyocytes and demonstrate the potential of proteomics to unravel dynamic changes in protein composition that may contribute to the neurohormonal regulation of myofilament contraction.
authors.affiliation: King's British Heart Foundation Centre, King's College London, London SE5 9NU, United Kingdom.
authors.forename: Xiaoke
authors.initials: X
authors.lastname: Yin
authors.forename: Friederike
authors.initials: F
authors.lastname: Cuello
authors.forename: Ursula
authors.initials: U
authors.lastname: Mayr
authors.forename: Zhiqi
authors.initials: Z
authors.lastname: Hao
authors.forename: Martin
authors.initials: M
authors.lastname: Hornshaw
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Ehler
authors.forename: Metin
authors.initials: M
authors.lastname: Avkiran
authors.forename: Manuel
authors.initials: M
authors.lastname: Mayr
mesh_terms: D008841:Actin Cytoskeleton / Q000737:chemistry* / Q000187:drug effects / Q000378:metabolism; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000818:Animals; D002478:Cells, Cultured; D019332:Endothelin-1 / Q000378:metabolism; D007545:Isoproterenol / Q000494:pharmacology*; D008297:Male; D051379:Mice; D009200:Myocardial Contraction / Q000502:physiology; D032383:Myocytes, Cardiac / Q000737:chemistry* / Q000187:drug effects / Q000378:metabolism; D018377:Neurotransmitter Agents / Q000502:physiology; D010766:Phosphorylation; D010770:Phosphotransferases / Q000032:analysis / Q000378:metabolism; D054645:Protein Phosphatase 1 / Q000032:analysis / Q000378:metabolism; D054648:Protein Phosphatase 2 / Q000032:analysis* / Q000378:metabolism; D020543:Proteome / Q000032:analysis* / Q000378:metabolism; D040901:Proteomics / Q000379:methods; D051381:Rats; D012518:Sarcomeres / Q000737:chemistry / Q000378:metabolism; D053719:Tandem Mass Spectrometry
chemical_list: D000318:Adrenergic beta-Agonists; D019332:Endothelin-1; D018377:Neurotransmitter Agents; D020543:Proteome; D010770:Phosphotransferases; C513662:B56alpha protein, rat; C499850:Ppp1r12a protein, rat; D054645:Protein Phosphatase 1; D054648:Protein Phosphatase 2; D007545:Isoproterenol